CEO Kevin T. Conroy of Exact Sciences to Be Interviewed Live on Clear Channel — iHeart Business Talk Radio — October 16, 2014
Interview Airs at 7:30am EDT / 4:30am PDT / 6:30am CDT on the Traders Network Radio Show, Hosted by Michael Yorba
DALLAS, TX–(Oct 15, 2014) – “The Traders Network Show” broadcasted daily on Clear Channel — iHeart Radio DFW1190AM KFXR, is pleased to announce Exact Sciences (NASDAQ:EXAS) CEO Kevin T. Conroy will be interviewed live on Thursday, Oct 16th, at 7:30am EDT by host Michael Yorba streamed globally on iHeart Radio. Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.
In this exclusive two-segment interview, Mr. Conroy will talk about the development of Cologuard, the first and only FDA approved, noninvasive stool DNA screening test for colorectal cancer.
We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen via Clear Channel’s nationally syndicated iHeart Radio stream.
Date: October 16, 2014
Start Time: 7:30am EDT | 4:30am PDT | 6:30am CDT (U.S.)
Network: Clear Channel – iHeart
Station: DFW 1190AM
KFXR Show: The Traders Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted “The Traders Network Show” broadcasted live daily on Clear Channel DFW 1190AM KFXR from 6am – 7:30am and 2pm – 3pm CT, Monday-Friday. Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.
About Exact Sciences Corp.
Exact Sciences Corp. (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Stool DNA technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please visit the company’s website at www.exactsciences.com, follow us on Twitter @ExactSciences or find us on Facebook.
A CommPro Worldwide PR Event…
PR & Media Contact:
Matt Bird, CEO
C: +1 (646) 401-4499
For more information visit: commpro.com | Twitter | LinkedIn | Facebook
Sorry, the comment form is closed at this time.